Interstitial deletion of 10q23.1 and confirmation of three 10qdel syndromes.

Singapore Med J

Diagnostic Genetics, LabPlus, Auckland City Hospital, PO Box 110031, Auckland 1148, New Zealand.

Published: July 2011

AI Article Synopsis

Article Abstract

A five-year-old girl with global developmental delay and mild dysmorphic features was referred for karyotyping. Cytogenetic analysis identified an interstitial deletion in the approximate position of chromosome band 10q23.1. The patient's DNA was analysed using an Affymetrix SNP6.0 array, and a 7.46Mbp deletion was detected within the region 10q22.3-q23.32. The deletion encompasses the BMPR1A gene, but does not extend as far as the phosphatase and tensin homolog (PTEN) locus. The location and extent of the deletion is the first of a small group of 10q deletion patients, which has been characterised at the level of resolution afforded by a SNP6.0 chip. Essentially, this case confirms that patients with microdeletions in the 10q23 region can be further divided into three sub-classes, depending on whether the deletion encompasses the BMPR1A gene, the PTEN gene or both.

Download full-text PDF

Source

Publication Analysis

Top Keywords

interstitial deletion
8
deletion encompasses
8
encompasses bmpr1a
8
bmpr1a gene
8
deletion
6
deletion 10q231
4
10q231 confirmation
4
confirmation three
4
three 10qdel
4
10qdel syndromes
4

Similar Publications

Six at Sixty. 'Have you tested for 22q?'.

J Med Genet

January 2025

Developmental Biology and Cancer, UCL GOS Institute of Child Health, London, UK

In 1997, the published our paper on the spectrum of clinical features associated with interstitial chromosome 22q11 deletions. This copy number variation is associated with an extraordinary range of clinical features, which led initially to its association with several diagnostic labels. Since 1997 work on clinical and basic science aspects of the syndrome and the genes reduced to hemizygosity have provided a wealth of information pertaining to both best practice care and underlying biology.

View Article and Find Full Text PDF

Renal fibrosis is a common pathway involved in the progression of various chronic kidney diseases to end-stage renal disease. Recent studies show that mitochondrial injury of renal tubular epithelial cells (RTECs) is a crucial pathological foundation for renal fibrosis. However, the underlying regulatory mechanisms remain unclear.

View Article and Find Full Text PDF

Non-Canonical TERT Activity Initiates Osteogenesis in Calcific Aortic Valve Disease.

Circ Res

January 2025

Division of Cardiology, Department of Medicine, Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, PA. (R.A.C., C.C.C., R.W., A.C., C.B., C.R., W.J.M., M.J. Bashline, A.P., A.M.P., P.B., M.J. Brown, C.S.H.).

Background: Calcific aortic valve disease is the pathological remodeling of valve leaflets. The initial steps in valve leaflet osteogenic reprogramming are not fully understood. As TERT (telomerase reverse transcriptase) overexpression primes mesenchymal stem cells to differentiate into osteoblasts, we investigated whether TERT contributes to the osteogenic reprogramming of valve interstitial cells.

View Article and Find Full Text PDF

Successful treatment of epidermal growth factor receptor exon 19 deletion non-small cell lung cancer with almonertinib after osimertinib-induced interstitial lung disease: A case report.

J Cancer Res Ther

December 2024

Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Shandong, China.

Osimertinib, a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI), has revolutionized one of the standard most efficient treatments for EGFR mutation-positive non-small cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently one of most efficient treatments in clinical practice. However, it has a potentially fatal side effect: interstitial lung disease (ILD).

View Article and Find Full Text PDF

Background: Familial adenomatous polyposis (FAP) is an autosomal dominant colorectal tumour syndrome characterised by the formation of multiple adenomatous polyps throughout the colon. It is important to understand the extracolonic phenotype that characterizes FAP. Most previous case reports of patients with both FAP and intellectual disability (ID) have described deletions in all or part of chromosome 5q, including the APC locus.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!